Trials / Completed
CompletedNCT00050622
Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
ADHD Treatment: Comparative and Combined Dosage Effects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 154 (actual)
- Sponsor
- Florida International University · Academic / Other
- Sex
- All
- Age
- 5 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the effectiveness of behavioral treatment, drug treatment, and combined treatment for children with Attention Deficit Hyperactivity Disorder (ADHD). This study will also examine the interactions between different levels of behavioral and drug treatments.
Detailed description
Participants attend a summer treatment program each Monday-Friday for 9 weeks. They participate in group recreational and classroom activities, with 12 children and 5 staff per group. Three behavioral conditions (no behavioral modification, low-intensity behavioral modification, and high-intensity behavioral modification) are delivered in random order, with each condition lasting 3 weeks. Along with the behavioral treatment conditions, children receive 1 of 4 medication doses (placebo, 0.15 mg/kg methylphenidate, 0.3 mg/kg methylphenidate, or 0.6 mg/kg methylphenidate) in random order, with each dose varied daily and repeated 3 or 4 times within each behavioral treatment condition. Measures include frequency counts of positive and negative behaviors, academic productivity and accuracy in the classroom, and counselor, parent, and teacher ratings of benefits and side effects. Parents attend training sessions and implement behavioral programs at home.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methylphenidate 0.15 mg/kg | 0.15 m/kg/dose immediate-release methylphenidate |
| BEHAVIORAL | Low-Intensity BMOD | Lower-intensity behavioral treatment package. |
| DRUG | Methylphenidate 0.3 mg/kg | 0.3 mg/kg/dose immediate-release methylphenidate |
| DRUG | Placebo | |
| DRUG | Methylphenidate 0.6 mg/kg | 0.3 mg/kg/dose immediate-release methylphenidate |
| BEHAVIORAL | High Intensity BMOD | Comprehensive high-intensity Summer Treatment Program (STP) |
Timeline
- Start date
- 2001-09-01
- Primary completion
- 2004-08-01
- Completion
- 2005-06-01
- First posted
- 2002-12-17
- Last updated
- 2016-09-30
- Results posted
- 2016-09-30
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00050622. Inclusion in this directory is not an endorsement.